STOCK TITAN
  1. Home
  2. CNST

Constellation Pharmaceuticals (CNST) Stock Price, News & Analysis

CNST NASDAQ

Company Description

Constellation Pharmaceuticals (NASDAQ: CNST) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for CNST, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
47.9M
Shares outstanding

Latest News

View All
—

MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology

acquisition
+0.36%

MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals

acquisition
+0.30%

Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

0.00%

Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting

clinical trial
+65.86%

MorphoSys to Acquire Constellation Pharmaceuticals

acquisition
+2.17%

Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

conferences

Constellation Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, clinical trial, conferences, earnings, earnings date. View all CNST news →

SEC Filings

View All

No SEC filings available for CNST.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CNST Company Profile & Sector Positioning

Constellation Pharmaceuticals (CNST) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.